Dr. Thorsteinn Skulason, MD

Dr. Skulason practices at Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee in Mequon, Wisconsin.

Dr. Skulason's NPI, 1275506081, was assigned on February 10, 2006. Dr. Skulason holds Wisconsin license 46417.

Dr. Skulason's primary practice is Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee, at 13111 North Port Washington Road, Mequon, WI 53097. The practice phone is (262) 243-6127.

Dr. Skulason's primary practice is Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee in Mequon, Wisconsin. The medical group on file is Madison Medical Affiliates. Dmand AI also links Dr. Skulason to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skulason practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Skulason's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Skulason is licensed in Wisconsin.

CMS data shows 950 Medicare services from Dr. Skulason across 11 procedure codes in 2024, for 345 Medicare patients. Medicare paid $34,402 for them. Every service was in an office.

CMS counts 345 Medicare patients who saw Dr. Skulason in 2024. The largest group is 65 to 74, with 158 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skulason's median patient age at 66, with 51% women.

In 2024, Dr. Skulason wrote 800 Medicare Part D claims for 277 patients. 82% of them were for generic drugs. CMS names the drug for 674 of them, across 20 drugs with 11 or more claims each, at $607,222 in total drug cost. In 2023, CMS named 559 claims across 18 drugs.

Dr. Skulason accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 228 procedures of removal of skin lesions by Dr. Skulason, more than 80% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 112 general payments to Dr. Skulason from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sanofi and Genzyme US Companies paid the most, $499.